AtaiBeckley (ATAI) Capital Expenditures (2020 - 2025)

AtaiBeckley (ATAI) recorded quarterly Capital Expenditures of $268000.0 in Q1 2025.

AtaiBeckley (ATAI) Capital Expenditures (2020 - 2025) Analysis & Trends

AtaiBeckley has disclosed Capital Expenditures across 6 years of filings, most recently posting -$395000.0 for Q3 2025.

  • Capital Expenditures for Q3 2025 came in at -$395000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $6000.0 (down 92.5% YoY), and the FY2024 annual result was $6000.0, down 98.19% from the prior year.
  • Capital Expenditures was $268000.0 for Q1 2025 at AtaiBeckley.
  • In the past five years, Capital Expenditures ranged from a high of $603000.0 in Q4 2022 to a low of -$395000.0 in Q3 2025.
  • The 5-year median for Capital Expenditures is $123000.0 (2021), against an average of $137666.7.
  • Across the five-year window, Capital Expenditures jumped 35100.0% in 2021 and tumbled 198.57% in 2023, its largest moves.
  • AtaiBeckley's Capital Expenditures stood at $305000.0 in 2021, then surged by 97.7% to $603000.0 in 2022, then plunged by 86.73% to $80000.0 in 2023, then plunged by 92.5% to $6000.0 in 2024, then tumbled by 6683.33% to -$395000.0 in 2025.
  • The last three Capital Expenditures figures came in at -$395000.0 (Q3 2025), $127000.0 (Q2 2025), and $268000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 AtaiBeckley 1.45 Bn 1.45 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -395,000.00
Sep 30, 2025 -395,000.00
Jun 30, 2025 127,000.00
Jun 30, 2025 127,000.00
Mar 31, 2025 268,000.00
Mar 31, 2025 268,000.00
Mar 31, 2025 268,000.00
Mar 31, 2025 268,000.00
Dec 31, 2024 6,000.00
Dec 31, 2024 6,000.00
Dec 31, 2023 80,000.00
Dec 31, 2023 80,000.00
Sep 30, 2023 -69,000.00
Sep 30, 2023 -69,000.00
Jun 30, 2023 40,000.00
Jun 30, 2023 40,000.00
Mar 31, 2023 280,000.00
Mar 31, 2023 280,000.00
Dec 31, 2022 603,000.00
Dec 31, 2022 603,000.00